275 related articles for article (PubMed ID: 26185978)
1. Dietary Fatty Acids and Their Potential for Controlling Metabolic Diseases Through Activation of FFA4/GPR120.
Ulven T; Christiansen E
Annu Rev Nutr; 2015; 35():239-63. PubMed ID: 26185978
[TBL] [Abstract][Full Text] [Related]
2. Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases.
Christiansen E; Watterson KR; Stocker CJ; Sokol E; Jenkins L; Simon K; Grundmann M; Petersen RK; Wargent ET; Hudson BD; Kostenis E; Ejsing CS; Cawthorne MA; Milligan G; Ulven T
Br J Nutr; 2015 Jun; 113(11):1677-88. PubMed ID: 25916176
[TBL] [Abstract][Full Text] [Related]
3. The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines.
Senatorov IS; Moniri NH
Biochem Pharmacol; 2018 Apr; 150():170-180. PubMed ID: 29452095
[TBL] [Abstract][Full Text] [Related]
4. Free-fatty acid receptor-4 (GPR120): Cellular and molecular function and its role in metabolic disorders.
Moniri NH
Biochem Pharmacol; 2016 Jun; 110-111():1-15. PubMed ID: 26827942
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological Tool Compounds for the Free Fatty Acid Receptor 4 (FFA4/GPR120).
Hansen SV; Ulven T
Handb Exp Pharmacol; 2017; 236():33-56. PubMed ID: 27807695
[TBL] [Abstract][Full Text] [Related]
6. Functions of omega-3 fatty acids and FFA4 (GPR120) in macrophages.
Im DS
Eur J Pharmacol; 2016 Aug; 785():36-43. PubMed ID: 25987421
[TBL] [Abstract][Full Text] [Related]
7. FFA4 (GPR120) as a fatty acid sensor involved in appetite control, insulin sensitivity and inflammation regulation.
Im DS
Mol Aspects Med; 2018 Dec; 64():92-108. PubMed ID: 28887275
[TBL] [Abstract][Full Text] [Related]
8. GPR120: Mechanism of action, role and potential for medical applications.
Karakuła-Juchnowicz H; Róg J; Juchnowicz D; Morylowska-Topolska J
Postepy Hig Med Dosw (Online); 2017 Nov; 71(0):942-953. PubMed ID: 29176006
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic signaling of the free-fatty acid receptors FFA1 and FFA4 in human breast carcinoma cells.
Karmokar PF; Moniri NH
Biochem Pharmacol; 2022 Dec; 206():115328. PubMed ID: 36309079
[TBL] [Abstract][Full Text] [Related]
10. FFA4 receptor (GPR120): A hot target for the development of anti-diabetic therapies.
Liu HD; Wang WB; Xu ZG; Liu CH; He DF; Du LP; Li MY; Yu X; Sun JP
Eur J Pharmacol; 2015 Sep; 763(Pt B):160-8. PubMed ID: 26123847
[TBL] [Abstract][Full Text] [Related]
11. [Free Fatty Acid Receptor Family: A New Therapeutic Target for Metabolic Diseases].
Hirasawa A
Yakugaku Zasshi; 2015; 135(6):769-77. PubMed ID: 26028412
[TBL] [Abstract][Full Text] [Related]
12. Ca2+ signaling in taste bud cells and spontaneous preference for fat: unresolved roles of CD36 and GPR120.
Abdoul-Azize S; Selvakumar S; Sadou H; Besnard P; Khan NA
Biochimie; 2014 Jan; 96():8-13. PubMed ID: 23774298
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases.
Wannick M; Bezdek S; Guillen N; Thieme M; Meshrkey F; Mousavi S; Seeling M; Nimmerjahn F; Mócsai A; Zillikens D; Sezin T; Sadik CD
Pharmacol Res Perspect; 2018 Dec; 6(6):e00438. PubMed ID: 30455959
[TBL] [Abstract][Full Text] [Related]
14. The beneficial effects of n-3 polyunsaturated fatty acids on diet induced obesity and impaired glucose control do not require Gpr120.
Bjursell M; Xu X; Admyre T; Böttcher G; Lundin S; Nilsson R; Stone VM; Morgan NG; Lam YY; Storlien LH; Lindén D; Smith DM; Bohlooly-Y M; Oscarsson J
PLoS One; 2014; 9(12):e114942. PubMed ID: 25541716
[TBL] [Abstract][Full Text] [Related]
15. Anti-Inflammatory and Insulin-Sensitizing Effects of Free Fatty Acid Receptors.
Miyamoto J; Kasubuchi M; Nakajima A; Kimura I
Handb Exp Pharmacol; 2017; 236():221-231. PubMed ID: 27873088
[TBL] [Abstract][Full Text] [Related]
16. [Free fatty acid receptors and their physiological role in metabolic regulation].
Hirasawa A; Hara T; Ichimura A; Tsujimoto G
Yakugaku Zasshi; 2011; 131(12):1683-9. PubMed ID: 22129861
[TBL] [Abstract][Full Text] [Related]
17. Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4.
Milligan G; Alvarez-Curto E; Watterson KR; Ulven T; Hudson BD
Br J Pharmacol; 2015 Jul; 172(13):3254-65. PubMed ID: 25131623
[TBL] [Abstract][Full Text] [Related]
18. Treatment with TUG891, a free fatty acid receptor 4 agonist, restores adipose tissue metabolic dysfunction following chronic sleep fragmentation in mice.
Gozal D; Qiao Z; Almendros I; Zheng J; Khalyfa A; Shimpukade B; Ulven T
Int J Obes (Lond); 2016 Jul; 40(7):1143-9. PubMed ID: 26980479
[TBL] [Abstract][Full Text] [Related]
19. Free fatty acid receptor GPR120 and pathogenesis of obesity and type 2 diabetes mellitus.
Mo XL; Wei HK; Peng J; Tao YX
Prog Mol Biol Transl Sci; 2013; 114():251-76. PubMed ID: 23317787
[TBL] [Abstract][Full Text] [Related]
20. Functional expression of the free fatty acids receptor-1 and -4 (FFA1/GPR40 and FFA4/GPR120) in bovine endometrial cells.
Valenzuela P; Teuber S; Manosalva C; Alarcón P; Figueroa CD; Ratto M; Burgos RA; Hidalgo MA
Vet Res Commun; 2019 Aug; 43(3):179-186. PubMed ID: 31187404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
